serw-MX  [xml]  
 


    
 DeCS Categories

C01 Bacterial Infections and Mycoses .
C01.539 Infection .
C01.539.800 Skin Diseases, Infectious .
C01.539.800.200 Dermatomycoses .
C01.539.800.200.675 Sporotrichosis .
C01.703 Mycoses .
C01.703.295 Dermatomycoses .
C01.703.295.675 Sporotrichosis .
C05 Musculoskeletal Diseases .
C05.116 Bone Diseases .
C05.116.900 Spinal Diseases .
C05.116.900.596 Posterior Cervical Sympathetic Syndrome .
C10 Nervous System Diseases .
C10.720 Neurotoxicity Syndromes .
C11 Eye Diseases .
C11.204 Corneal Diseases .
C11.204.236 Corneal Dystrophies, Hereditary .
C11.204.236.438 Fuchs' Endothelial Dystrophy .
C11.270 Eye Diseases, Hereditary .
C11.270.162 Corneal Dystrophies, Hereditary .
C11.270.162.438 Fuchs' Endothelial Dystrophy .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.290 Eye Diseases, Hereditary .
C16.320.290.162 Corneal Dystrophies, Hereditary .
C16.320.290.162.410 Fuchs' Endothelial Dystrophy .
C17 Skin and Connective Tissue Diseases .
C17.800 Skin Diseases .
C17.800.838 Skin Diseases, Infectious .
C17.800.838.208 Dermatomycoses .
C17.800.838.208.675 Sporotrichosis .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.915 Wasting Syndrome .
C18.654 Nutrition Disorders .
C18.654.940 Wasting Syndrome .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.470 Inflammation .
C25 Chemically-Induced Disorders .
C25.723 Poisoning .
C25.723.705 Neurotoxicity Syndromes .
C26 Wounds and Injuries .
C26.844 Sprains and Strains .
C26.844.150 Cumulative Trauma Disorders .
E03 Anesthesia and Analgesia .
E03.155 Anesthesia .
E04 Surgical Procedures, Operative .
E04.270 Endocrine Surgical Procedures .
E04.270.532 Hypophysectomy .
E04.270.532.490 Hypophysectomy, Chemical .
G02 Chemical Phenomena .
G02.111 Biochemical Phenomena .
G02.111.830 Structure-Activity Relationship .
G02.111.830.500 Quantitative Structure-Activity Relationship .
G07 Physiological Phenomena .
G07.690 Pharmacological and Toxicological Phenomena .
G07.690.773 Pharmacological Phenomena .
G07.690.773.997 Structure-Activity Relationship .
G07.690.773.997.500 Quantitative Structure-Activity Relationship .
VS4 Environmental Health Surveillance .
VS4.002 Surveillance of the Workers Health .
VS4.002.001 Occupational Health .
VS4.002.001.002 Occupational Medicine .
VS4.002.001.002.001 Occupational Diseases .
VS4.002.001.002.001.002 Cumulative Trauma Disorders .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Inflammation .
Inflammations .
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. .
1.00
 
Anesthesia .
A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. .
0.41
 
Posterior Cervical Sympathetic Syndrome .
Syndrome of Barre-Lieou .
Barre Lieou Syndrome .
Syndrome of Barre Lieou .
Syndrome, Barre-Lieou .
Barre-Lieou Syndrome .
A pathological condition that is characterized by a host of cranial symptoms, such as headaches, abnormal functions of the eyes and the ears, and psychological and mental disorders. This syndrome usually appears after neck injuries, inflammation, or neoplasm. .
0.38
 
Neurotoxicity Syndromes .
Encephalopathy, Toxic .
Nervous System Poisoning .
Neurotoxic Disorders .
Neurotoxin Diseases .
Neurotoxin Disorders .
Toxic Encephalitis .
Encephalitides, Toxic .
Encephalitis, Toxic .
Encephalopathies, Toxic .
Nervous System Poisonings .
Neurotoxic Disorder .
Neurotoxicity Syndrome .
Neurotoxin Disease .
Neurotoxin Disorder .
Poisonings, Nervous System .
Syndrome, Neurotoxicity .
Syndromes, Neurotoxicity .
Toxic Encephalitides .
Toxic Encephalopathies .
Toxic Encephalopathy .
Poisoning, Nervous System .
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents. .
0.37
 
Fuchs' Endothelial Dystrophy .
Fuch's Endothelial Dystrophy .
Fuchs Atrophy .
Fuchs Corneal Dystrophy .
Fuchs Dystrophy .
Fuchs Endothelial Corneal Dystrophy .
Fuchs Endothelial Dystrophy .
Dystrophy, Fuch's Endothelial .
Dystrophy, Fuchs' Endothelial .
Endothelial Dystrophy, Fuch's .
Endothelial Dystrophy, Fuchs' .
Fuch Endothelial Dystrophy .
Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain. .
0.36
 
Quantitative Structure-Activity Relationship .
3D-QSAR .
QSAR 23179 .
QSPR Modeling .
Quantitative Structure Property Relationship .
3D QSAR .
3D-QSARs .
Modeling, QSPR .
Quantitative Structure Activity Relationship .
Quantitative Structure-Activity Relationships .
Relationship, Quantitative Structure-Activity .
Relationships, Quantitative Structure-Activity .
Structure-Activity Relationship, Quantitative .
Structure-Activity Relationships, Quantitative .
Structure Activity Relationship, Quantitative .
A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. .
0.36
 
Sporotrichosis .
Sporothrix schenckii Infection .
Infection, Sporothrix schenckii .
Infections, Sporothrix schenckii .
Sporothrix schenckii Infections .
Sporotrichoses .
The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with SPOROTHRIX. .
0.36
 
Hypophysectomy, Chemical .
Chemical Hypophysectomy .
Chemical Hypophysectomies .
Hypophysectomies, Chemical .
Total or subtotal destruction of the pituitary gland by chemical injection. It is usually achieved by injection of ethyl alcohol via trans-sphenoidal cannulation under stereotaxic control. It is usually performed for the treatment of intractable pain. .
0.35
 
Wasting Syndrome .
Wasting Diseases .
Wasting Syndromes .
Wasting Disease .
A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism. .
0.34
 
Cumulative Trauma Disorders .
Injury, Repetition Strain .
Overuse Injury .
Repetitive Motion Disorders .
Repetitive Strain Injury .
Repetitive Stress Injury .
Strain Injury, Repetition .
Cumulative Trauma Disorder .
Disorder, Cumulative Trauma .
Disorder, Repetitive Motion .
Disorders, Cumulative Trauma .
Disorders, Repetitive Motion .
Injuries, Overuse .
Injuries, Repetition Strain .
Injuries, Repetitive Strain .
Injuries, Repetitive Stress .
Injury, Overuse .
Injury, Repetitive Strain .
Injury, Repetitive Stress .
Motion Disorder, Repetitive .
Motion Disorders, Repetitive .
Overuse Injuries .
Overuse Syndromes .
Repetition Strain Injuries .
Repetitive Motion Disorder .
Repetitive Strain Injuries .
Repetitive Stress Injuries .
Strain Injuries, Repetition .
Strain Injuries, Repetitive .
Strain Injury, Repetitive .
Stress Injuries, Repetitive .
Stress Injury, Repetitive .
Trauma Disorder, Cumulative .
Trauma Disorders, Cumulative .
Repetition Strain Injury .
Overuse Syndrome .
Harmful and painful condition caused by overuse or overexertion of some part of the musculoskeletal system, often resulting from work-related physical activities. It is characterized by inflammation, pain, or dysfunction of the involved joints, bones, ligaments, and nerves. .
0.34